Banking & Fintech

Sulzer releases mixed results

This content was published on Jan 20, 2000 The industrial and medical technology group, Sulzer, has reported another mixed set of sales figures. The group as a whole has announced a two per cent increase for 1999, but that masks some considerable differences in performance. Once again, Sulzer Medica is the star of the group, reporting a rise in sales of eight per…

New boss plans shake-up of Locarno film festival

This content was published on Jan 19, 2000 The new president of the Locarno International Film Festival, Giuseppe Buffi, says the organisation has to adopt a more professional approach, if it’s to survive in the long-term. Buffi, a member of the Swiss Senate, said Locarno had to introduce professional structures, if it was to stave off eventual financial collapse. Speaking at his first…

Novartis reportedly seeking merger partners

This content was published on Jan 19, 2000 The Swiss life sciences giant, Novartis, is looking for merger partners in the United States, according to a report in Britain’s Financial Times newspaper. The paper says Novartis has its sights on a tie-up with with American Home Products or Pharmacia and Upjohn. Citing sources close to the company, the FT says Novartis is exploring…

Swiss Life to shed 280 jobs

This content was published on Jan 19, 2000 The insurance company Rentenanstalt/Swiss Life says it is going to shed 280 jobs over the next year. The company says most of losses will be among its administrative staff, but it does not anticipate any forced redundancies – it says the jobs will be shed through voluntary resignations and retirements. The cuts come as part…

Swiss government plans tighter rules for GM crops

This content was published on Jan 19, 2000 The cabinet plans to introduce tighter regulations for producers of genetically-modified organisms, but has stopped short of imposing a complete ban on the planting of GM crops. The draft proposal aims to protect bio-diversity and the dignity of living creatures, without stifling further research. The seven-member Swiss cabinet had indicated that a complete ban on…

Swisscom to launch mobile Internet services

This content was published on Jan 18, 2000 Switzerland’s largest telecommunications operator, Swisscom, has announced that it is to launch a new era in technology next month. It is bringing the Internet mobile phone service to Switzerland with the new worldwide standard called Wireless Application Protocol (WAP). Swisscom says that after the explosion in use of the Internet and the mobile phone over…

Davos summit organisers play down threat of protests

This content was published on Jan 18, 2000 The World Economic Forum has rejected accusations of a lack of transparency and is playing down the threat of disruption by demonstrators when its annual meeting opens in Davos on January 27. At a presentation of the elite meeting’s line-up at the Forum’s headquarters in Geneva, the organisers said they had invited 650 media representatives…

Ares-Serono registers record sales

This content was published on Jan 18, 2000 The biotechnology company, Ares-Serono, has posted strong double digit growth, with 1999 sales up 14.8 per cent. Sales have broken through the SFr1.5 billion($1 billion) threshold for the first time, with fourth quarter sales up more than eight per cent to a record of more than SFr430 million. “Surpassing our goal of $1 billion in…

Swiss Federal Railways moots merger

This content was published on Jan 17, 2000 There have been further reports about a possible merger between the Swiss Federal Railways and the BLS Lötschberg Railway. A Federal Railways spokesman, Reto Kormann, confirmed that the issue had been raised during discussions between the two railways on increased co-operation. He added that savings of up to SFr50 million could be made annually if…

Swiss pharmaceutical giants relaxed about Glaxo merger

This content was published on Jan 17, 2000 The big Swiss pharmaceutical companies, Roche and Novartis, say they are relaxed about the news of the merger between the two British giants, Glaxo Wellcome and Smithkline Beecham. It will create the biggest pharmaceuticals group in the world, worth nearly 200 billion dollars. Novartis, which ranks sixth in the world, said it was strong enough…

Banking & Fintech

Popular Stories

Most Discussed

Banking & Fintech

More

Sulzer releases mixed results

More

New boss plans shake-up of Locarno film festival

More

Novartis reportedly seeking merger partners

More

Swiss Life to shed 280 jobs

More

Swiss government plans tighter rules for GM crops

More

Swisscom to launch mobile Internet services

More

Davos summit organisers play down threat of protests

More

Ares-Serono registers record sales

More

Swiss Federal Railways moots merger

More

Swiss pharmaceutical giants relaxed about Glaxo merger

Popular Stories

Most Discussed